Chris Hill
Analyst · Johnson Rice
Thanks, Larry. Before we review the financial performance for the quarter, the guidance we gave on our last call and past calls excluded the impact of any FX gains and losses and assumed an effective tax rate of 25%. So accordingly, our discussion today excludes any foreign exchange gain or loss for current and prior periods. The comparison periods for the first quarter of 2026 and the second quarter of 2025 also included items that were discussed in those calls and highlighted in our earnings release for those periods. These items have also been excluded from our discussion of the financial results today. You can find a summary of those items in the tables attached to our press release for the second quarter of 2026. Now looking at the income statement, revenue was $124.6 million in the second quarter, up over 2% compared to the prior quarter and down 4% year-over-year. Sequentially, we saw increased demand for our completion products in both the U.S. land and international markets, while service revenue increased in certain international regions. The conflicts in both Russia, Ukraine, and the Middle East, which have intensified, have primarily impacted our service revenue. Of this revenue, service revenue, which is more international, was $94.3 million for the quarter, flat sequentially and down 2% year-over-year. Our service revenue associated with crude assay services and regional studies continue to be impacted by the geopolitical conflicts in the Middle East and Russia, Ukraine, which are the primary reason for the year-over-year decrease. However, growth in other regions outside these affected areas offset some of the impact. Sequentially, although the Middle East and Russia have been significantly impacted, service revenue was flat. We continue to see demand improve for our reservoir rock and fluid analytical programs in certain international regions where exploration programs are more active. Additionally, our well completion diagnostic services continue to perform well in the U.S. market and is showing some growth internationally, excluding the Middle East. Product sales, which are more equally tied to North America and international activity, were $30.3 million for the quarter and were up 10% sequentially, but down 11% year-over-year. Sequentially, completion activity in the U.S. improved modestly. However, we saw significant growth in our U.S. completion product sales. Switching to international product sales, which are typically larger bulk orders and can vary from one quarter to another, were also up nicely compared to the first quarter. When looking at year-over-year, we had a large laboratory instrumentation sale last year, which did not repeat in the second quarter of 2026. However, this was partially offset by improved sales of perforating products in both the U.S. and international markets. Moving on to cost of services ex items for the quarter was 80% of service revenue, a slight improvement from 81% in the prior quarter and increased from 77% last year. Sequential improvement was primarily driven by continued cost reduction initiatives in regions impacted by the conflicts. The year-over-year increase is primarily result of the company continuing to carry costs in the regions, which have been more negatively impacted in 2026 by the escalation of conflicts in both the Middle East and Russia, Ukraine. As discussed on prior calls, the service side of our business has been more affected by geopolitical conflicts and expanded sanctions. Volatility in crude oil prices, along with continued conflict in Russia, Ukraine, and the Middle East, have disrupted regional operations and reduced demand for our crude assay services, which are closely tied to the trading and maritime movement of crude oil and derived products. We will continue to manage our cost structure as effectively as possible as we work through these disruptions in certain regions. Cost of sales ex items in the second quarter was 85% of revenue, which improved from 94% in the prior quarter and was relatively flat compared to last year. Sequential improvement was primarily driven by continued cost control initiatives and manufacturing efficiencies. With these initiatives in place, we anticipate the manufacturing absorption rate in future periods to be in line with projected product sales. Additionally, in the second quarter of 2026, we received a partial refund of import tariffs, which were incurred in prior periods. G&A ex items for the quarter was $11 million, which was relatively flat compared to the prior quarter, and up slightly from the same quarter in the prior year. For 2026, we expect G&A ex items to be approximately $43 million to $45 million. It is also important to note that 100% of our corporate G&A expenses are allocated and absorbed into the financial performance of the reported segments. Depreciation and amortization for the quarter was $3.8 million, flat compared to the prior quarter. EBIT ex items for the quarter was $9.4 million, up from $6.6 million last quarter, yielding an EBIT margin of approximately 8% and expanding 210 basis points from last quarter. Our EBIT for the quarter on a GAAP basis was $9.2 million. Interest expense of $2.8 million for the second quarter compares to $2.9 million in the prior quarter and $2.7 million in the same quarter in the prior year. The changes in interest expense were primarily due to changes in our average borrowings with variable interest rates during the periods. Income tax expense at an effective tax rate of 25% and ex items was $1.6 million for the quarter. On a GAAP basis, we recorded tax expense of $500,000 for the quarter. The second quarter expense includes benefits from certain discrete items recorded in the quarter. The effective tax rate will continue to be somewhat sensitive to the geographic mix of earnings across the globe and the impact of items discrete to each quarter. We continue to project the company's effective tax rate to be approximately 25%. Net income ex items for the quarter was $5.1 million, up sequentially from $2.7 million last quarter, but down from $8.8 million in the second quarter of last year. On a GAAP basis, we had net income of $6 million for the quarter. Earnings per diluted share ex items was $0.11 for the quarter, compared to $0.06 in the prior quarter, and $0.19 in the second quarter of last year. On a GAAP basis, EPS was $0.13 for the quarter. Turning to the balance sheet, receivables were $108.8 million and increased slightly from the prior quarter. Our DSOs for the second quarter were at 73 days, which improved slightly from 74 days last quarter. The timing of collections have been impacted by the ongoing conflicts, and we continue to remain focused on our collection efforts in the affected regions. Inventory at June 30, 2026, was $58 million, up slightly from last quarter-end. Inventory turns for the quarter were 1.8 and remained the same compared to last quarter. With continued focus, we anticipate inventory turns will gradually improve as we progress through the remainder of 2026. And now to the liability side of the balance sheet. Our long-term debt was $116.4 million as of June 30, 2026, and considering cash of $22.7 million, net debt was $93.6 million, which decreased slightly from the last quarter. Our leverage ratio is currently at 1.3 compared to 1.2 last quarter. Our debt is currently comprised of $65 million in senior notes, a term loan of $49.4 million and $2 million outstanding under our bank credit facility. Looking at cash flow. For the second quarter of 2026, cash flow from operating activities was $7.8 million, and after paying approximately $4.7 million of CapEx for operations, our free cash flow for the quarter was $3.1 million. Cash from operations almost doubled this quarter when you compare it to the first quarter. However, our capital expenditures were also higher. The elevated capital expenditures are primarily associated with investments to support a recently signed multi-year contract in the Asia-Pacific region and rebuilding our facilities in the Mediterranean region, which incurred weather-related damage in the first quarter. As discussed in prior quarters, the capital expenditures associated with rebuilding our U.K. facility, which was damaged by fire are covered by the company's property and casualty insurance and have been excluded in the calculation of free cash flow. In the second quarter of 2026, capital expenditures associated with rebuilding the U.K. facility were $1.1 million. Looking ahead to the rest of the year, we will continue our strict capital discipline and asset-light business model with capital expenditures primarily targeted at growth opportunities. Excluding the CapEx associated with rebuilding the U.K. facility, we expect capital expenditures for the full year of 2026 to be in the range of $15 million to $18 million. Core Lab's operational leverage continues to provide the ability to grow revenue and profitability with minimal capital requirements. Capital expenditures for operations has historically ranged from 2% to 4% of revenue, even during periods of significant growth. That same level of laboratory infrastructure, intellectual property, and leverage exists in the business today. We believe evaluating a company's ability to generate free cash flow and free cash flow yield is an important metric for shareholders when comparing and projecting companies' financial results, particularly for those shareholders who utilize discounted cash flow models to assess valuations. I will now turn it over to Gwen for an update on our guidance and outlook.